InspireMD Inc

FRA:II2 (Israel)  
€ 2.18 (+0.93%) Mar 28
At Loss
P/B:
1.27
Market Cap:
€ 51.42M ($ 55.47M)
Enterprise V:
€ 16.80M ($ 18.13M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

Business Description

InspireMD Inc
NAICS : 339112 SIC : 3841
ISIN : US45779A8615
Description
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
Name Current Vs Industry Vs History
Cash-To-Debt 24.47
Equity-to-Asset 0.83
Debt-to-Equity 0.04
Debt-to-EBITDA -0.08
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.85
Distress
Grey
Safe
Beneish M-Score -2.26
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 48.23
9-Day RSI 43.03
14-Day RSI 41.84
6-1 Month Momentum % -15.54
12-1 Month Momentum % 145.34

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.34
Quick Ratio 6.99
Cash Ratio 6.48
Days Inventory 148.71
Days Sales Outstanding 79.65
Days Payable 59.31

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -88.1
Shareholder Yield % 0.05

Financials (Next Earnings Date:2024-05-16 Est.)

FRA:II2's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

InspireMD Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 5.752
EPS (TTM) (€) -0.977
Beta -0.27
Volatility % 85.5
14-Day RSI 41.84
14-Day ATR (€) 0.054089
20-Day SMA (€) 2.254
12-1 Month Momentum % 145.34
52-Week Range (€) 0.905 - 3.42
Shares Outstanding (Mil) 23.46

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

InspireMD Inc Filings

Filing Date Document Date Form
No Filing Data

InspireMD Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

InspireMD Inc Frequently Asked Questions

What is InspireMD Inc(FRA:II2)'s stock price today?
The current price of FRA:II2 is €2.18. The 52 week high of FRA:II2 is €3.42 and 52 week low is €0.91.
When is next earnings date of InspireMD Inc(FRA:II2)?
The next earnings date of InspireMD Inc(FRA:II2) is 2024-05-16 Est..
Does InspireMD Inc(FRA:II2) pay dividends? If so, how much?
InspireMD Inc(FRA:II2) does not pay dividend.

Press Release

Subject Date
No Press Release